این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Basic and Clinical Cancer Research، جلد ۶، شماره ۲، صفحات ۲۳-۲۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Inhibin as A Tumor Marker in Postmenopausal Women with Ovarian Malignancies
چکیده انگلیسی مقاله Background: Inhibin is a dimeric glycoprotein that has a depressive effect on the anterior hypophyse secretion. The level of this tumor marker is undetectable in menopause women. In patients with gynecological cancer, especially granulosa and epidermal-type (mucinous), ovarian cancers considerable increase in the serum level of Inhibin has been reported. The increased level of Inhibin has been reported in patients with recurrent ovarian cancer. Methods: We measured total serum Inhibin and CA125 tumor marker level in 38 postmenopausal women with pathologically confirmed ovarian cancer before and after surgery out of 51 suspected women. Our control group were postmenopausal women that attended to our clinic for routine gynecologic checkup. Both tumor markers were measured in these patients too. Results: Among 38 women with ovarian cancer, 13(34.2%) had elevated serum levels of total Inhibin. Among the 16 women with serous adenocarcinoma, 3 patients (18.8%) had elevated serum levels of Inhibin. All the three women with granulosa cell tumor had elevated serum levels of Inhibin (100%) and 3 of 4(75%) women with mucinous ovarian cancer had the same result. three out of 38 women in control group had elevated serum levels of Inhibin . Among all 38 patients, 6(15.7%) showed tumor recurrence, that all were concomitant with rising of both serum CA125 and Inhibin levels (p=0/001). Conclusions: Serum Inhibin level is a useful tumor marker in granulosa cell and in mucinous tumor of ovary. In this study combined Inhibin and CA125 assay showed better results in early detection of ovarian cancer in comparison to either CA125 or Inhibin alone.
کلیدواژه‌های انگلیسی مقاله Inhibin, tumor marker, ovarian cancer
نویسندگان مقاله میترا مدرس گیلانی | mitra modarres guilani
department of obstetrics amp;amp; gynecology, oncology vali-e-asr hospital, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

مهشید کریمی | mahshid karimi
department of obstetrics amp;amp; gynecology, oncology vali-e-asr hospital, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

نشانی اینترنتی http://bccr.tums.ac.ir/index.php/bccrj/article/view/124
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات